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ARTICLE
Integrin-linked kinase controls retinal angiogenesis
and is linked to Wnt signaling and exudative
vitreoretinopathy
Hongryeol Park1,13, Hiroyuki Yamamoto 1,8,13, Lucas Mohn2,9, Lea Ambühl2, Kenichi Kanai 1, Inga Schmidt1,
Kee-Pyo Kim 3, Alessia Fraccaroli4,10, Silke Feil2, Harald J. Junge 5,11, Eloi Montanez 4,12,
Wolfgang Berger2,6,7* & Ralf H. Adams 1*
Familial exudative vitreoretinopathy (FEVR) is a human disease characterized by defective
retinal angiogenesis and associated complications that can result in vision loss. Defective
Wnt/β-catenin signaling is an established cause of FEVR, whereas other molecular altera-
tions contributing to the disease remain insufﬁciently understood. Here, we show that
integrin-linked kinase (ILK), a mediator of cell-matrix interactions, is indispensable for retinal
angiogenesis. Inactivation of the murine Ilk gene in postnatal endothelial cells results in
sprouting defects, reduced endothelial proliferation and disruption of the blood-retina barrier,
resembling phenotypes seen in established mouse models of FEVR. Retinal vascularization
defects are phenocopied by inducible inactivation of the gene for α-parvin (Parva), an
interactor of ILK. Screening genomic DNA samples from exudative vitreoretinopathy patients
identiﬁes three distinct mutations in human ILK, which compromise the function of the gene
product in vitro. Together, our data suggest that defective cell-matrix interactions are linked
to Wnt signaling and FEVR.
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Appropriate growth of blood vessels is critical for theproper development of most organs and, consequently,defective angiogenesis is linked to several congenital
human diseases. Familial exudative vitreoretinopathy or FEVR is
a genetic disorder in which impaired angiogenesis in the retina of
young children can lead to aberrant neovascularization and
symptoms, such as the formation of retinal folds and tears, retinal
detachment, or even total vision loss1. Among the genes asso-
ciated with FEVR, components of the Wnt/β-catenin signaling
pathway are highly prevalent. These are the genes encoding the
growth factor Norrin (NDP), the receptor Frizzled-4 (FZD4), the
low-density lipoprotein receptor-related protein 5 (LRP5), and
tetraspanin-12 (TSPAN12), which forms transmembrane receptor
complexes with LRP5 and Frizzled-42,3. For other FEVR-
associated mutations, which affect a zinc ﬁnger family DNA-
binding protein (ZNF408), a kinesin family molecular motor
protein (KIF11) and a basic helix–loop–helix family transcription
factor (ATOH7), it is less clear whether they are functionally
related to Wnt/β-catenin signaling4–7. While several of the genes
linked to FEVR directly regulate endothelial cell (EC) behavior in
various animal models2,3,6,8–11, ATOH7 (also known as Math5) is
an important regulator of neuronal and glial development in the
retina12,13. Thus, some vitreoretinopathies might be caused by
primary defects outside the vasculature.
Integrin family receptors and associated components of the
cell–matrix adhesion machinery, such as focal adhesion kinase,
integrin-linked kinase, kindlin, or talin are also recognized key
regulators of EC function and angiogenesis14–17. ILK is an
important mediator of integrin signaling and forms a tripartite
complex (termed IPP) with PINCH and parvin adapter proteins,
which together regulate cell contractility, actin, and microtubule
organization, and cytoskeletal dynamics18. Constitutive, EC-
speciﬁc knockout of Ilk in mice leads to embryonic lethality
due to impaired vascularization of the embryo proper and the
labyrinthine layer in the placenta19. In ECs derived from Ilk
knockout embryonic stem cells, the organization of microtubules
and cortical actin ﬁlaments, the positioning of the scaffolding
protein caveolin 1, and the cellular responses to vascular endo-
thelial growth factor (VEGF) and epidermal growth factor (EGF)
are compromised20. Knockdown of ILK expression also impairs
the migration of human umbilical vein ECs (HUVECs) toward
VEGF and pharmacological ILK inhibition leads to reduced
tumor growth and angiogenesis in a xenograft model21. However,
the function of ILK in postnatal physiological angiogenesis in vivo
has not been studied so far and remains little understood.
In the current study, we use inducible EC-speciﬁc approaches
to show that the murine Ilk gene is indispensable for the vascu-
larization of the postnatal retina, a well-established model system
of angiogenesis22,23. Vascular defects in Ilk mutants resemble
phenotypes seen after inducible inactivation of the gene for α-
parvin (Parva) and those in previously established mouse models
of FEVR24. Furthermore, we identify three loss-of-function
mutations in human ILK in genomic DNA samples from exu-
dative retinopathy patients, which links defective cell–matrix
interactions to the development of this disease.
Results
Defects after inducible, EC-speciﬁc inactivation of Ilk. To cir-
cumvent the embryonic lethality of EC-speciﬁc Ilk mutants19 and
uncover the function of ILK in postnatal retinal angiogenesis,
mice carrying a loxP-ﬂanked allele of the gene25 were bred to
tamoxifen-inducible Pdgfb-iCre23 transgenic animals. Tamoxifen
was initially administered at postnatal day (P1) to P3 followed by
analysis of the resulting Pdgfb-iCre+/− Ilklox/lox (IlkiECKO) mutant
and Cre-negative control littermate retinas at P6 (Fig. 1a), which
allows detailed analysis of the growing superﬁcial vascular plexus.
Immunostaining of retina sections conﬁrmed that this approach
abolished ILK expression speciﬁcally in ECs but not in IlkiECKO
perivascular cells (Supplementary Fig. 1A). Vessel outgrowth as
well as vessel density and branching are reduced in IlkiECKO
retinas relative to littermate controls (Fig. 1b, e). Filopodia-
extending endothelial sprouts at the edge of the growing mutant
vessel plexus are present and even more abundant than in P6
control samples but remain short and display an abnormally thick
morphology with an enlarged lumen, as indicated by immunos-
taining of ICAM2, a cell adhesion molecule at the apical EC
surface facing the vessel lumen (Fig. 1b, c, e). Immunostaining of
transmembrane proteins connecting adjacent ECs, namely the
adherens junction protein VE–cadherin and the tight junction
protein Claudin 5, uncovers a highly increased complexity of
EC–EC contacts at the distal IlkiECKO vessel plexus (Fig. 1d;
Supplementary Fig 1B, C). Immunostaining for the transcription
factor Erg, which decorates endothelial nuclei, shows dense
clustering of mutant ECs within the thick IlkiECKO sprouts
(Fig. 1d). This clustering of ECs at the angiogenic front and in the
short sprouts together with the reduced outgrowth of the vessel
plexus is consistent with the important role of integrins and ILK
as regulators of cell migration26–28. In line with the overall
reduced vascular coverage and reduction of vessel branch points
in mutant retinas (Fig. 1e), IlkiECKO ECs show strongly reduced
proliferation relative to control samples (Fig. 1f, g).
After the initial outgrowth of the superﬁcial vessel plexus,
retinal vessels sprout perpendicularly into the deeper retina and
successively form two further capillary layers22. This process was
analyzed in P14 mice in which Ilk inactivation in ECs had been
induced by three tamoxifen injections at P3, P5, and P7 (Fig. 2a).
While three vessel layers are clearly distinguishable in P14 control
samples, vascularization of the deeper retina is defective in
IlkiECKO mutants (Fig. 2b–e). Detailed analysis of the IlkiECKO
retinal vasculature reveals that the perpendicular sprouting of
vessels from the superﬁcial plexus is strongly compromised.
Mutant sprouts are stalled in the vicinity of the nerve ﬁber layer
and form thick protrusions (Fig. 2c, d). Normal vessel remodeling
and maturation in the superﬁcial retina involves the pruning of
side branches and a gradual reduction of capillary diameters29.
These remodeling processes are impaired in P14 IlkiECKO retinas,
which display enlarged vessel diameters, excess branch points and
increased endothelial coverage in the superﬁcial vessel plexus
(Fig. 2b, c). Thus, loss of endothelial Ilk function not only leads to
defective endothelial sprouting but also interferes with vessel
remodeling.
FEVR-like vascular defects in Ilk mutant mice. Defective vas-
cularization of the deeper retina has been reported for mutant
mice lacking critical regulators of actin dynamics30–32 as well as
numerous components of the Wnt signaling pathway2. Mutations
in several human Wnt pathway genes have been also linked to
FEVR and, in particular, incomplete vascularization of the per-
ipheral retina combined with increased vessel leakage and
hemorrhaging in the eye10,11,33,34. Many of these disease features
are reproduced by EC-speciﬁc mouse mutants for Fzd4 and other
genes2,3, and are also phenocopied by Ilk mutant mice. P14 Ilk-
iECKO mutants are reduced in size and body weight (Fig. 3a) and
development of the retinal vasculature is severely compromised
(Fig. 3b). Endothelial sprouts penetrating from the vitreal surface
have been reported to terminate in thick, roundish clusters in EC-
speciﬁc Fzd4 mutants and global Fzd4, Lrp5, or Ndp knockout
mice2,3. Similar clusters are abundant in the IlkiECKO retinal
vasculature (Fig. 3d and Supplementary Fig. 2A). These endo-
thelial clusters are associated with macrophages, which are also
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Fig. 1 Postnatal EC-speciﬁc Ilk inactivation induces sprouting defects in retina. a IlkiECKO mutants and littermate controls received intraperitoneal tamoxifen
injections once daily from P1–3 and were analyzed at P6. b Low-magniﬁcation overview (top panels) and high-magniﬁcation images of angiogenic growth
front (bottom panels) in isolectin B4 stained control and IlkiECKO P6 retinas, respectively. Note reduction of vessel density and radial outgrowth in IlkiECKO
mutants despite the abundance of ﬁlopodia-extending ECs. Abnormally thick sprouts and EC clusters are detected in IlkiECKO samples (arrows). Scale bar,
200 μm (top panels), 25 μm (bottom). c ICAM2 (green) and isolectin B4 (blue) staining in P6 control and IlkiECKO retinas. The lumen of vessels, indicated
by apical ICAM2 signal, is enlarged in the leading edge of IlkiECKO capillaries. Scale bar, 25 μm. d Confocal images showing VE-cadherin (green) and Erg
(red) immunostaining in combination with isolectin B4 (blue) in control and IlkiECKO retinas, as indicated. Loss of Ilk leads to clustering of ECs at the growth
front and increases the complexity of EC–EC junctions. Scale bar, 25 μm. e Quantiﬁcation of outgrowth vs. retina diameter, branch points per ﬁeld and EC
area coverage in overview images of control and IlkiECKO retinas. Sprouts per angiogenic front and ﬁlopodia per vessel length at the front area are also
quantiﬁed. Error bars, s.e.m. p values (***p < 0.001, **p < 0.01), Student’s t test (n= 8 control and 6 mutants retinas). f, g Incorporation of EdU in isolectin
B4-stained control and IlkiECKO retinas. Representative confocal images (f) and quantiﬁcation (g) of proliferating ECs both in number per ﬁeld and relative
to EC-covered area. Scale bar, 50 μm. Error bars, s.e.m. p values (***p < 0.001, **p < 0.01), Student’s t test (n= 10 control and 8 mutant retinas). Source
data are provided as a Source Data ﬁle
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Fig. 2 ILK is indispensable for plexus formation in the deeper retina. a IlkiECKO mutants and littermate controls received intraperitoneal tamoxifen injections
every other day from P3–7 and were analyzed at P14. b Isolectin B4-stained IlkiECKO mutants and littermate control retinas. Optical sections of z-stacked
confocal images were divided to represent the nerve ﬁber layer (NFL), inner plexiform layer (IPL), and outer plexiform layer (OPL). Note strong reduction of
the IlkiECKO IPL and OPL vasculature. Scale bar, 200 μm. c, d, XY-extended, ZY-extended, and XYZ plane view high magniﬁcation images of control and
IlkiECKO retinas stained with isolectin B4. Vertical sprouting is impaired and abnormal, bulging endothelial structures decorate dilated vessels in IlkiECKO
retinas. Scale bar, 100 μm (top) and 50 μm (bottom) in (c), 25 µm in (d). e Quantiﬁcation of branch points, vascular area coverage, vertical sprouts and
capillary vessel diameter, as shown in (b) and (c). Error bars, s.e.m. p values (***p < 0.001, **p < 0.01), Student’s t test (n= 6 retinas/group). Source data
are provided as a Source Data ﬁle
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Fig. 3 Vascular abnormalities in Ilk mutants phenocopy aspects of FEVR. a Picture and body weight analysis of P14 IlkiECKO mutants and littermate controls.
Error bars, s.e.m. p values (***p < 0.001), Student’s t test (n= 6 animals/group). b Overview images of the isolectin B4-stained P14 control and IlkiECKO
retinal vasculature. Scale bar, 500 μm. c Confocal images of the isolectin B4-stained vasculature in the control and IlkiECKO nerve ﬁber layer. Arteries (A),
veins (V), and bulging EC clusters emerging from mutant capillaries (arrows) are indicated. Scale bar, 100 μm. d High contrast images of isolectin B4-
stained vessels in the P14 nerve ﬁber layer. Filopodia-extending sprouts (arrowheads) can be seen on control capillaries, whereas blunt ends of IlkiECKO
vessels are associated with isolectin B4+macrophages (arrows). Scale bar, 25 μm. e Confocal images of β-catenin (green) and isolectin B4 (white) stained
control and IlkiECKO P6 retina sections. Presence (control) or absence (IlkiECKO) of β-catenin in endothelial nuclei (red arrows) in images with or without
DAPI signal. Scale bar, 20 μm. f Overview images of LEF1 and isolectin B4 stained retina of control and IlkiECKO. Arteries (A) and veins (V) are indicated.
Scale bar, 200 μm. g Confocal high magniﬁcation images of Pvlap (blue) and isolectin B4 (green) stained control and IlkiECKO retinas. Note enhanced Pvlap
staining of IlkiECKO vessels and strong signal in distal EC clusters (arrows). Scale bar, 50 μm. Source data are provided as a Source Data ﬁle
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-13220-3 ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:5243 | https://doi.org/10.1038/s41467-019-13220-3 | www.nature.com/naturecommunications 5
stained by isolectin B4, and the number of F4/80-positive mac-
rophages is increased in IlkiECKO retinas (Fig. 3d and Supple-
mentary Fig. 2B).
Arguing that the similarities between the IlkiECKO phenotype
and defects in the Wnt/β-catenin mutant retinal vasculature
might reﬂect a functional link, β-catenin immunosignals are
readily detectable in control but not in IlkiECKO EC nuclei
(Fig. 3e). The transcription factor LEF1 (lymphoid enhancer-
binding factor 1), one of the transcriptional mediators of Wnt/
β-catenin signaling, marks nuclei in venous and capillary ECs
in P6 and P14 control retinas (Fig. 3f; Supplementary Fig. 2C).
Intriguingly, venous LEF1 expression is strongly reduced in P14
IlkiECKO retinas, whereas arteries show ectopic LEF1 immuno-
signal (Supplementary Fig. 2C). Further arguing for defective
maturation and integrity of the IlkiECKO vasculature, pro-
nounced hemorrhaging is seen in mutant retinas and brain
whole-mounts and sections (Supplementary Fig. 3A, B). The
latter is most prominent in the cerebellum, which is similar to
brain hemorrhaging reported for Fzd4-deﬁcient mice2,3 and
consistent with an important role of Wnt signaling in the
establishment of the blood–brain barrier (BBB) and
blood–retina barrier (BRB)35,36. Expression of Pvlap/PV1,
which forms diaphragms in endothelial fenestrae, is character-
istic for immature, highly permeable or fenestrated vessels, but
is downregulated in the normal postnatal vasculature of
the central nervous system (CNS)37–39. While only weak Pvlap
immunostaining is detectable in P14 control capillaries, signals
are strongly elevated in IlkiECKO vessels and, in particular, in
roundish endothelial clusters (Fig. 3g). These ﬁndings establish
that loss of endothelial Ilk compromises BBB and BRB function,
leads to hemorrhaging and causes FEVR-like vascular defects
in mice.
ILK forms functional, heterotrimeric IPP complexes with the
adapter proteins PINCH (particularly interesting Cys-His-rich
protein) and parvin, which stabilize each other, link integrin
receptors to the actin cytoskeleton and control downstream signal
transduction18,40. Endothelial α-parvin (encoded by the gene
Parva) is essential for angiogenesis in embryonic and postnatal
mice, which involves the regulation of the cell adhesion molecule
VE-cadherin24. Inactivation of Parva in the postnatal endothe-
lium leads to the appearance of EC clusters and sprouting defects
resembling those seen in IlkiECKO retinas (Fig. 4a–c). Likewise,
vascularization of the deeper retina is strongly impaired in EC-
speciﬁc ParvaiECKO mutants (Fig. 4d). These results support that
physiological retinal angiogenesis requires ILK, α-parvin and
therefore presumably also the formation of IPP complexes.
As global loss of Ilk gene function in mice is incompatible with
preimplantation development, we also investigated the vascula-
ture of heterozygous, EC-speciﬁc mutants (IlkiECKO/+). While
these mice appear normal and display extensive vascularization of
both the superﬁcial and deeper retina (Fig. 5a), the number of
vessel projections from the vitreal surface as well as vessel density
and number of branch points in the deep retinal plexus are
signiﬁcantly reduced (Fig. 5a–d). Despite of the essential roles of
Ilk in preimplantation development, it has been reported that
heterozygous knockouts appear normal without any overt
anatomical or behavioral abnormalities41. To address potential
vascular alterations in global mutants lacking one functional allele
of Ilk, we interbred Ilklox/lox conditional animals with the PGK-
Cre deleter strain42. Constitutive Ilk+/− heterozygous knockout
mice generated with this breeding strategy and control littermates
show no overt differences in body weight or the vascularization of
the superﬁcial retina (Supplementary Fig. 4A, B). However,
vascularization of the deeper retina is compromised, as indicated
by signiﬁcant reductions in the number of vessel branch points,
vascular density, and vertical vessel projections from the vitreal
surface in P14 Ilk+/− retinas relative to littermate controls
(Supplementary Fig. 4C, D). These results establish that EC-
speciﬁc IlkiECKO/+ and global Ilk+/− mutants develop similar
vascular phenotypes and highlight that ECs respond sensitively to
the loss of a single Ilk allele.
ILK variants in human patients. Based on the identiﬁcation of
FEVR-like defects in IlkiECKO retinas, a cohort of genomic DNA
samples from 208 exudative vitreoretinopathy patients, most of
them sporadic cases with unknown genetic cause, were screened by
Sanger sequencing for mutations in the 12 protein coding exons as
well as ﬂanking splice sites of the human ILK gene. This approach
revealed three distinct missense mutations in the open reading
frame of ILK in four patients but in none of the control samples
(420 controls= 840 alleles). Two of the patients are heterozygous
for the variant p.Arg211Cys (NM_004517.2:c.631C > T), which
converts an arginine into a cysteine residue within the phosphati-
dylinositol 3,4,5-triphosphate (PIP3)-binding region of ILK
(Fig. 6a–c). Arg211 is highly conserved among vertebrate and
invertebrate species and it was previously shown that an ILK
Arg211Ala variant protein is impaired in its ability to induce
protein kinase B (PKB/Akt) phosphorylation in cultured cancer cell
lines43,44. A second Ilk variant, p.Leu53Met (NM_004517.2:c.157T
> A) alters a highly conserved leucine residue within the N-terminal
ankyrin repeat region, which is important for binding of PINCH
and ILK associated serine/threonine phosphatase (ILKAP)45
(Fig. 6a–c). The variant p.Arg317Gln (NM_004517.2:c.950G >A)
alters a residue within the ILK kinase domain (Fig. 6a–c)45. The
catalytic activity of ILK was previously shown to be dispensable for
normal development and tissue function in knock-in mice, but
residues with the kinase domain are nonetheless critical for α-
parvin binding and thereby for ILK function46–48. Thus, the three
newly identiﬁed ILK variants are likely to affect the biological
activity of the gene product. Moreover, all three variants
occur more frequently than mutations in human NDP or
other FEVR-associated genes, but are, nevertheless, not very fre-
quent (p.Leu53Met: 0.035%; pArg211Cys: 0.084%; p.Arg317Gln:
0.0016%) and mostly conﬁned to European subjects within the data
set of the Exome Aggregation Consortium (ExAC)49. Consistent
with the essential roles of ILK in development, no homozygotes for
the three alleles were found in the ExAC database.
ILK variants represent partial loss-of-function alleles. To study
the biological activity of the three variants identiﬁed above, we
designed human ILK constructs, which are resistant to siRNA
targeting without changing the amino acid sequence of the
resulting gene products (Fig. 6d). The detection of these pro-
teins was facilitated by an aminoterminal fusion to green
ﬂuorescent protein (GFP-ILK) in some experiments. For
knockdown of endogenous ILK expression in HUVECs, we used
a siRNA targeting exon 2, which strongly reduces the expression
of endogenous ILK (Fig. 7a). Knockdown of ILK expression
impairs cell spreading and leads to a pronounced reduction of
paxillin-containing focal adhesions and focal complexes in
transfected HUVECs (Fig. 7b). These defects are rescued by
expression of siRNA-resistant GFP-ILK but not by GFP alone.
Remarkably, all three mutated versions of GFP-ILK fail to
restore normal HUVEC spreading and focal adhesion organi-
zation (Fig. 7b), which is most obvious for the L53M and R211C
variants.
Interactions between ILK, PINCH and parvin are critical for
the stability of these proteins in the tripartite IPP complex40.
Immunoprecipitation of overexpressed and GFP-tagged wild-type
ILK leads to pull-down of associated PINCH and α-parvin,
whereas PINCH co-immunoprecipitation is strongly reduced for
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L53M, R211C, and R317Q ILK (Fig. 7c). In contrast, expression
levels and ILK immunoprecipitation efﬁciencies are indistin-
guishable for wild-type GFP-ILK and all three variants (Fig. 7c).
This is even more obvious after siRNA-mediated knockdown of
ILK expression, which strongly reduces endogenous ILK protein
levels but also the stability of PINCH and α-parvin in HUVECs
(Supplementary Fig. 5B). These defects are rescued by re-
expression of wild-type GFP-ILK but not by the L53M and
R317Q variants. R211C has an intermediate effect in this assay
and allows the pull-down of associated PINCH and α-parvin,
which is strongly reduced for L53M and R317Q (Supplementary
Fig 5B).
Previous work has linked ILK to phosphorylation of PKB/AKT
in cultured cancer cells and ﬁbroblasts43,50, which also reﬂects
ILK-dependent cell–matrix interactions and integrin activation.
AKT phosphorylation (in Ser473) but not total AKT is reduced
after ILK knockdown in HUVECs, which is not rescued by
expression of the R211C, R317Q, or L53M ILK variant (Fig. 7a;
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Supplementary Fig 5A). Moreover, endothelial phospho-AKT
immunostaining is strongly diminished in IlkiECKO retina
sections relative to littermate control (Fig. 7d). ILK knockdown
in HUVECs reduces the levels of β-catenin, which is rescued by
re-expression of wild-type ILK, but not any of three variant
proteins (Fig. 7a; Supplementary Fig 5A). Arguing further for a
role of ILK in Wnt signaling, knockdown of integrin-linked
kinase in HUVECs or HRMVECs (primary human retinal
microvascular ECs) impairs the upregulation of the Wnt target
genes AXIN2, SOX17, and FLT1 in response to stimulation with
recombinant hNorrin (Fig. 7e and Supplementary Fig. 5C).
hNorrin-induced upregulation of AXIN2 in this setting is
signiﬁcantly restored by re-expression of wild-type ILK but not
any of the three variants (Fig. 7e).
ILK has oncogenic activity44,51, which can be readily assessed
by focus formation assays in culture. Overexpression of wild-type
ILK in NIH 3T3 cells induces the formation of foci signiﬁcantly
above the level seen for vector control (Supplementary Fig. 5D).
In contrast, the number of foci obtained after overexpression of
any of the three ILK variants is comparable to vector control
(Supplementary Fig. 5D). Together, all these assays indicate that
the sequence changes in L53M, R211C, and R317Q ILK reduce
the biological activity of the gene product, indicating that the
variants identiﬁed in FEVR patients are functional hypomorphs.
Our data also show that ECs react sensitively to changes in ILK
level and activity, which involves changes in cell morphology,
behavior, and Wnt signaling.
Discussion
ILK is an indispensable regulator of cell–matrix signaling in many
different cell types and organ systems, and, accordingly, global
inactivation of the murine Ilk gene leads to impaired epiblast
polarization and preimplantation lethality41. Likewise, con-
stitutive loss of Ilk in ECs leads to embryonic lethality at mid-
gestation19 as soon as development requires the proper function
of the vasculature and placenta. The current study has used EC-
speciﬁc and inducible genetic approaches, which have provided
insights into Ilk function in postnatal angiogenesis and have
linked the gene to exudative vitreoretinopathy. The vascular
defects of IlkiECKO mutants are phenocopied by EC-speciﬁc
inactivation of Parva, which highlights the importance of the
interactions between ILK, PINCH, and parvin proteins in the IPP
complex. Our data also indicate that β-parvin cannot compensate
for the loss of α-parvin in ECs and is consistent with previous
reports assigning distinct functional roles to the two proteins in
mammalian cells52. The IPP complex associates with integrin
heterodimers and thereby couples extracellular signals to a variety
of intracellular processes such as signal transduction, cytoskeletal
dynamics, or membrane trafﬁcking18. Postnatal, EC-speciﬁc
mutant mice lacking integrin β1 (Itgb1iECKO), a subunit that
can form complexes with 12 distinct integrin α chains, also
develop a range of vascular defects such as hemorrhaging and
compromised angiogenesis53. However, Itgb1iECKO mutants dis-
play EC hyperproliferation in retinal veins and at the angiogenic
growth front, whereas EC proliferation is reduced in Ilk and
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Parva mutants24. While Itgb1iECKO retinal vessels fail to extend
endothelial sprouts, mutant ECs do not accumulate in distal focal
clusters as those seen in IlkiECKO or ParvaiECKO retinas. These
differences might indicate that other signals, such as growth
factor receptors54, are acting upstream of ILK in ECs. Alter-
natively, it is also feasible that integrin heterodimers involving
other β subunits are responsible for the phenotypic differences. In
fact, integrin β3 and β5 suppress pathological angiogenesis even
though they are not required for developmental vessel
growth55,56.
Most of the gene mutations observed in FEVR patients affect
the Wnt signaling pathway and the corresponding mutant mouse
models show vascular defects1,3,8–11,57 that are strikingly similar
to the IlkiECKO phenotype. Indeed, Wnt and ILK cooperate in
processes such as hair follicle polarization, skin homeostasis and
bone formation58–60. ILK was also shown to regulate the stabi-
lization and nuclear translocation of β-catenin, an essential
component of the Wnt pathway, in cultured cells61–63. Our data
show that ILK depletion in ECs reduces β-catenin levels in vitro
and in vivo, blunts the cellular response to recombinant hNorrin,
and leads to alterations in LEF1 expression in the retinal vascu-
lature. Thus, the two pathways appear to be functional linked in
the CNS endothelium, explaining the striking similarities in
mutant phenotypes.
While autosomal dominant and X-linked inheritance is most
common for FEVR, autosomal recessive inheritance has been also
described34. The three variants of human ILK identiﬁed in
patients suffering from exudative vitreoretinopathy represent
partial loss-of-function alleles, which raises the question whether
development of the disease requires the loss of heterozygosity in
ECs. A similar situation has been reported for cerebral cavernous
malformation (CCM), a human disease characterized by the
development of hyperpermeable vascular malformations in the
brain. While familial CCM is caused by heterozygous mutations
in one of the three relevant genes, namely CCM1/KRIT1, CCM2,
or CCM3/PDCD10, vascular lesions in mice emerge only in
homozygous mutants64,65. The essential roles of ILK in many cell
types and organs might prevent the widespread emergence of
homozygous loss-of-function cells early in development, but
future work will have to address whether disease onset requires
the loss of heterozygosity in ECs or their progenitors. As muta-
tions in the LAMA4 gene, which encodes the extracellular matrix
protein laminin-α4, and in ILK (p.Ala262Val; c.C785T) have been
associated with human cardiomyopathy66,67, ILK and other
proteins mediating matricellular interactions emerge as key reg-
ulators of cardiovascular morphogenesis and might be function-
ally relevant in FEVR and other human diseases involving the
vascular system.
Methods
Mice. Animal experiments were performed in compliance with the relevant laws
and institutional guidelines, were approved by local animal ethics committees and
were conducted with permissions granted by the Landesamt für Natur, Umwelt
und Verbraucherschutz (LANUV) of North Rhine-Westphalia or Animal Experi-
ments of the Ludwig-Maximilians University Munich.
Pdgfb-iCre transgenic mice23 were bred into a background of Ilk68 conditional
(loxP-ﬂanked) mice, whereas conditional Parva24 mutants were combined with
Cdh5-CreERT2 animals. To induce Cre activity, newborn offspring were given
intraperitoneal tamoxifen injections of 50 μg (P1–3) or 100 μg (P3–7) and the
phenotypes analyzed at P6 or P14, respectively. ParvaiECKO mutants were analyzed
at P16 after tamoxifen injection at P1–3. In all genetic experiments, tamoxifen-
injected littermate animals were used as control, and both male and female animals
were used.
For the generation of constitutive Ilk+/− heterozygous mice, PGK-Cre
transgenic mice were interbred with Ilk68 conditional (loxP-ﬂanked) animals.
Analysis of the resulting mice was done at P6 and P14.
Immunohistochemistry and EdU labeling of whole-mount retina. All immu-
nostainings of retina were carried out with littermate processed simultaneously
under the same conditions, as described previously69. To analyze (and quantitate)
the morphology of the retinal vasculature and preserve intact endothelial ﬁlopodia
and sprouts at the angiogenic front, whole animal eyes were ﬁxed in 4% PFA at
4 °C overnight. The following day, eyes were washed in phosphate-buffered saline
(PBS) before retinas were dissected and partially cut in four quadrants. After
blocking/permeabilization in 1% bovine serum albumin (BSA) with 0.3% Triton X-
100 for several hours at RT or overnight at 4 °C, the retinas were washed two times
in Pblec buffer (1% Triton X-100, 1 mM CaCl2, 1 mM MgCl2, and 0.1 mM MnCl2
in PBS [pH 6.8]) for 20 min and incubated for overnight in Pblec containing
biotinylated isolectin B4 (VectorLabs, B-1205, 1:50). Following ﬁve washes (each
20 min) in blocking solution, retinas were incubated with Alexa Fluor streptavidin-
conjugated antibodies (Life Technologies, S11223, 1:100) for 2 h, washed three
times more and ﬂat-mounted in microscope glass slides with Fluoromount-G
(SouthernBiotech, 0100-01). Double or triple whole-mount immunohistochemistry
was performed in retinas ﬁxed 2 h on ice in 4% PFA or in MeOH at −20 °C. After
ﬁxation, retinas were blocked for 2 h in 1% BSA with 0.3% Triton X-100 and
incubated overnight or for 2 h with isolectin B4 (Vector Labs, B-1205, 1:50) and the
following primary antibodies: rat anti-VE-cadherin (BD Biosciences, 555289,
1:200), rabbit anti-Collagen IV (Serotec, 2150-1470, 1:200), rat anti-ICAM2 (BD
Biosciences, 553326, 1:200), rabbit anti-Claudin5 (Life Technologies, 341600,
1:200), rat anti-Plvap (Developmental Studies Hybridoma Bank, AB 531797, 1:15),
rabbit anti ERG (Abcam, ab110639, 1:100), and LEF1 (Cell signaling, #2230, 1:100).
For detection, suitable species-speciﬁc Alexa Fluor-coupled secondary antibodies
(Invitrogen, 1:500) were used.
Immunoﬂuorescence staining of retina sections. Whole retinas were ﬁxed in 4%
PFA overnight and dehydrated by stepwise buffer changes to 10, 20, and 30%
sucrose in PBS every day. After embedding in Tissue Freezing Medium (Leica),
50 µm sections are obtained using a cryotome (Leica CM3050S). To remove the
Tissue Freezing Medium, retina sections were washed twice with PBS at room
temperature (RT) for 15 min each. Following overnight blocking in 5% goat serum
with 0.3% Triton X-100 in PBS at 4 °C, primary antibodies or lectins were applied
in blocking solution: isolectin B4 (Vector Labs, B-1205, 1:50), ILK (Genetex,
GTX62096, 1:100), phospho-AKT (Cell signaling, #4060, 1:100) and β-catenin (Cell
signaling, #9562, 1:100). For signal detection, suitable species-speciﬁc Alexa Fluor-
coupled secondary antibodies (Alexa, 1:500) were used with 1:1000 DAPI.
Image acquisition and processing. Stained and ﬂat mounted retinas were ana-
lyzed at high resolution with Leica TCS SP5 and Zeiss LSM 880 confocal micro-
scopes. A Leica Stereomicroscope MZ16F coupled to a digital camera (Hamamatsu
C4742-95) was used for lower resolution. Volocity, IMARIS, Photoshop CS and
Illustrator CS (Adobe) software were used for image acquisition and processing. All
images shown are representative of at least six different images from three different
retina samples per group with identical laser excitation and confocal scanner
detection settings.
NIH3T3 cell culture and colony forming assay. For the colony formation assay,
6 × 105 of NIH 3T3 cells (Sigma #93061524) were grown in 24-well plates and
transfected with 0.8 µg of pHygEF2-based expression plasmid that also contained a
hygromycin-resistant marker, using lipofectamine 2000 reagent (Invitrogen).
Twenty-four hours after transfection, the cells were trypsinized and seeded into
60-mm dishes. The cells were further grown in D-MEM containing 3% FBS and
100 μg/mL hygromycin for 3 weeks and then stained with crystal violet.
Cloning of ILK expression vector constructs. Cloning of ILK expression con-
structs was performed in the Gateway cloning system (Invitrogen). cDNAs were
modiﬁed with a CACC sequence in front of the start codon and with three stop
codons at the 3′ end to allow site-directed cloning into the pEntry/D-TOPO vector.
Mutations were generated by site-directed mutagenesis. The mutagenesis poly-
merase chain reaction (PCR) was performed using the proof-reading polymerase
Pfu (Promega). All expression constructs were sequence veriﬁed prior to use in
transfection assays.
To construct the pHygEF2/3xHA-h-ILK (wild-type or mutant) plasmid, a
double-stranded oligonucleotide encoding the 3xHA-tag was inserted into the
pHygEF2 vector after BssHII-ClaI digestion. Then, the human ILK open reading
frame was ampliﬁed by PCR from pBABE-puro/EGFP-FLAG-h-ILK plasmid using
primers (5′-AAAATCGATACTAGTATGGACGACATTT-3′ and 5′-
AAATCTAGACTACTTGTCCTGCATCTTC-3′) and inserted into the ClaI-
XbaI sites.
Immunoprecipitation and Western blot. Cell extracts were prepared by direct
addition of 4× sodium dodecyl sulfate (SDS) sample buffer (200 mm Tris–HCl,
(pH 6.8), 8% SDS, 400 mm dithiothreitol, 0.2% bromophenol blue, 40% glycerol) to
the cells or by cell lysis in lysis buffer (1% NP-40, 1 % Triton-X, 50 mM Tris
(pH 8.0), 150 mM NaCl, protease and phosphatase inhibitor cocktail). For
immunoprecipitation, anti-GFP (Abcam, ab6556) or anti-FLAG agarose (MBL,
FLA-1) was used. After extensive washing with lysis buffer, the precipitates were
dissolved in 2× SDS sample buffer. Samples were loaded on SDS–polyacrylamide
gel and electrophoresis and Western blotting was performed. Blots were quantiﬁed
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with the gel analysis function in the program ImageJ. The following antibodies
were used for immunoblotting: anti-PINCH (BD, 612710, 1: 5,000), anti-α-parvin
(Abcam, ab11336, 1: 5000), anti-ILK (Abcam, ab49979, 1: 5000), anti-tubulin
(Sigma, T3526, 1: 5000), anti-FLAG (Sigma, F7425, 1: 5000), anti-β-catenin (Cell
signaling, #8814, 1:11,000), anti-AKT (Cell signaling, #4691, 1:5000), and anti-
phospho-AKT(ser473) (Cell signaling, #4060, 1:1000). Uncropped versions of the
Western blots shown in Fig. 7a, c and Supplementary Fig. 5B as well as additional
replicate blots used for the quantitation shown in Supplementary Fig. 5A, B are
provided in Supplementary Figs. 6–8.
Quantitative analysis of the retinal vasculature. All quantiﬁcations were done
on high-resolution confocal images representing a thin z-section of the sample. The
number of branchpoints and the area covered by ECs were calculated with the
Volocity (Perkin Elmer) software from 24 ﬁelds sized 770 × 770 μm, 6 retina
samples per group. The number of endothelial sprouts and ﬁlopodial extensions
were quantiﬁed at the angiogenic front in 24 ﬁelds (sized 385 × 385 μm, 6 retinas
per group) of control and ILKiECKO retinas. The total number of ﬁlopodia was
normalized for a standard size (100 μm in length) of vessels at the angiogenic front.
EdU labeled, isolectin B4-positive ECs were counted in 16 ﬁelds (sized 385 ×
385 μm, 4 retinas per group). Vascular progression/outgrowth was measured by
deﬁning a straight line from the angiogenic front to the center of the retina for each
retina quadrant. A minimum of 16 quadrants belonging to 4 retinas per group were
used for quantiﬁcation.
EC culture and transfection. HUVECs purchased from Thermo Fisher (C0035C)
were maintained in Medium200 (M200) supplemented with low serum growth
supplement (Life Technologies). HUVECs at passage 3–6 were used for experi-
ments. HUVECs seeded on 0.2% Gelatin (Sigma) coated dishes at the day before
transfection and transfected with 100 nM of siRNAs for human ILK (5′-GCCU-
GUGGCUGGACAACACGGAGAA-3′), by using oligofectamine (Life Technolo-
gies) according to the manufacturer’s instructions. For transient expression of
human wild-type or mutant ILK (p.L53M, p.R317Q, and p.R211C) which is siRNA
resistant, HUVECs were transfected with one of these vectors or control (without
insert) by using oligofectamine (Life Technologies) according to the manufacturer’s
instructions. Immunostaining, western, or immunoprecipitation were done 48 h
after transfection.
Lentiviral expression vector cloning and virus production. The coding region of
ILK and its mutants which are modiﬁed to have resistant to siRNA of ILK were
ampliﬁed by PCR and cloned into NcoI and SalI sites of pHAGE2-TetO plasmid.
pHAGE2-TetO-mCherry was used for estimating the infection rate and control. All
constructs were veriﬁed extensively by restriction enzyme digestion and sequen-
cing. To produce the lentivirus, HEK293 cells were transfected with 3 μg of psPAX2
(Addgene), 1.5 μg of pMD2.G (Addgene), and 4.5 μg of lentiviral vector using 27 μl
of Fugene 6 (Promega) transfection reagent in 600 µl of Opti-MEM. Virus-
containing supernatants were collected at 48 h, ﬁltered through a 0.4-µm PVDF
ﬁlter, concentrated, and resuspended in knockout DMEM and stored at −80 °C
until use.
Norrin. For stimulation with recombinant Norrin, wild-type, and mutants ILK
expression lentivirus infected HUVECs were used which ILK expression is con-
trolled by doxycycline treatment. After lentiviral infection, infected HUVECs were
reseeded on 0.2% gelatin coated 60 mm dish. At following day, infected HUVECs
were transfected with ILK siRNA by using RNAiMAX (Thermo) manufacturer’s
instructions for 4 h and change with complete medium with 5 ng/ml of doxycyclin.
The knockdown efﬁciency sustained for 72 h after transfection. Totally, 24 h after
siRNA transfection, stimulation wth 1.25 µg/ml recombinant human Norrin (R&D
Systems) was performed for 8 h and RNA is isolated by RNA is isolated by RNeasy
mini kit (Quiagen). qPCR is performed with SsoAdvanced Universal Probes
Supermix (BIO-RAD) with Taqman primer: ILK (Hs00177914_m1), Axin2
(Hs00610344_m1), Sox17 (Hs00751752_s1), and FLT1 (Hs01052936_m1).
HRMVECs (ACBRI181, Cell Systems) were transfected with 20 nM of pooled or
single siRNA (Dharmacon) with RNAimax. After 24 h, cells were split at 50 K into
6-well plates. Twelve hours later cells were stimulated with 1.25 μg/ml hNorrin for
48 h. Total RNA was extracted using Trizol (Invitrogen) and digested with DNase
(Stratagene) and used for RT-qPCR.
Analysis of phospho-AKT and β-catenin in HUVEC. Lentivirus infected
HUVECs were used for western blotting for analysis of phospho-AKT and β-
catenin. At 24 h after seeding of cells in 0.2% gelatin coated 100 mm dishes, lysates
were prepared with RIPA buffer containing 1× complete protease inhibitor (Roche)
and 1× PhosSTOP (Roche) and quantiﬁed by the Bradford assay (Bio-Rad).
Western blotting was performed as described above.
Immunoﬂuorescence analysis of HUVECs. HUVECs were transferred from a
100 mm dish into a 6-well plate after transfection or infection. Cells were ﬁxed with
4% PFA in RT for 10 min. After 2 rounds of brief washing with PBS, permeabi-
lization/blocking solution (1% BSA with 0.2% triton x-100 in PBS) was added to
the ﬁxed cells for 30 min at RT. Rabbit anti-Paxillin (Cell Signaling, 1:100) and
mouse anti-GFP (Chemicon, 1:100) in PBS were administered for 1 h at RT. Fol-
lowing three washes with PBS (5 min each), suitable species-speciﬁc Alexa Fluor-
coupled secondary antibodies (1:500) were administered togehter with 1:1000
DAPI and samples were incubated for 25 min at RT. After three washes with PBS
(5 min each), stained cells were mounted on microscope glass slides with
Fluoromount-G (SouthernBiotech, 0100-01).
For labeling of proliferating cells, 100 μg of EdU (Life Technologies) per pup
was injected intraperitoneally 4 h before sacriﬁce. EdU-positive cells were detected
with the Click-iT EdU Alexa Fluor-647 Imaging Kit (Life Technologies, C10340).
DNA sequencing of patients and controls. Informed consent according to the
declaration of Helsinki was obtained from all subjects (208 patients and 258
controls) involved in genetic testing. The human ILK gene consists of 13 exons, 12
of which code for a protein of 452 amino acid residues. Protein coding exons and
ﬂanking intronic regions (including splice sites) were ampliﬁed by PCR and
sequenced using the Sanger chain termination sequencing method. The patients
were clinically diagnosed with exudative vitreoretinopathy or a similar disorder.
Most of them were sporadic cases and no additional family members were available
for segregation analysis of DNA sequence variations.
The study was conducted in accordance with the Helsinki Declaration. The
approval for genetic testing was awarded to the Institute of Medical Molecular
Genetics by the Federal Ofﬁce of Public Health (FOPH) in Switzerland. Patients
provided informed consent for genetic testing.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The source data underlying Figs. 1E, G, 2E, 3A, 4C, 5D, 7E, and Supplementary Figs. 4B,
D and 5A–D are provided as a Source Data ﬁle. The data that support the ﬁndings of this
study are available from the corresponding author upon reasonable request.
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